News

The company said that several formulations using Cobalamin, which is based upon the body’s natural absorption of vitamin B12 in the gastrointestinal tract, were tested in an animal

The most common non-hematologic toxicities were mild grade 1 and 2 nausea, diarrhea and vomiting. Blood concentrations of the active metabolite of Telintra tablets increased with dose levels.

The pre-determined $25 million purchase valuation of Altiva is based on Exactech’s sales multiple and Altiva’s trailing 12 months revenue. Exactech’s final payment of $7 million will consist

Under this agreement, Bristol-Myers Squibb and Gilead share responsibility for commercializing Atripla throughout the EU and certain other European countries. Gilead will record revenues from future net sales

The data showed inhibition of cell growth, decrease in Beta-catenin protein levels and potent induction of apoptosis in myeloma cells by the Beta-catenin pathway inhibitors. Gene expression biomarkers

Data from this study demonstrated that EZN-2208 treatment given as a single dose or in multiple dose regimen can cure animals bearing human non-Hodgkin’s lymphoma. EZN-2208 treatment cured

The trial, which is for women whose breast cancer has recurred after surgery, and is stable after having only partially responded to salvage chemotherapy, will be available for

The company also reported completion of long-term follow-up on 20 patients treated with the cPAX Aneurysm treatment system in a clinical study which was completed in May. Eric

Bard’s peripheral vascular division, located in Tempe, Arizona, will assume marketing responsibility for the product. The company expects to close the transaction following the satisfaction of customary conditions,